Cargando…
NLRP3 inflammasome activation in platelets in response to sepsis
Sepsis is a complex syndrome characterized by organ dysfunction and a dysregulated immune host response to infection. There is currently no effective treatment for sepsis, but platelets have been proposed as a potential therapeutic target for the treatment of sepsis. We hypothesized that the NLRP3 i...
Autores principales: | Cornelius, Denise C., Baik, Cedar H., Travis, Olivia K., White, Dakota L., Young, Cassandra M., Austin Pierce, W., Shields, Corbin A., Poudel, Bibek, Williams, Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499866/ https://www.ncbi.nlm.nih.gov/pubmed/31054188 http://dx.doi.org/10.14814/phy2.14073 |
Ejemplares similares
-
Platelet Inhibition Prevents NLRP3 Inflammasome Activation and Sepsis-Induced Kidney Injury
por: Borges-Rodriguez, Marivee, et al.
Publicado: (2021) -
NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture
por: Cornelius, Denise C., et al.
Publicado: (2020) -
Chronic infusion of interleukin‐17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats
por: Travis, Olivia K., et al.
Publicado: (2019) -
Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
por: Zhang, Ge, et al.
Publicado: (2021) -
The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)